News About: Pharm. Industry
Listed pharmaceutical firms’ operating profit nosedives 46% in 1Q
Korea’s 54 pharmaceutical firms saw their earnings plunge 45.9 percent during the first quarter, even before a government-mandated price cut came into effect, data showed on Monday.
According to the data compiled b...
14 smaller drug makers’ earnings halves in 1Q
Influenced by the government’s intensive campaign to prevent illegal kickbacks, 14 smaller companies with less than 100 billion won in sales saw their earnings shrink almost 50 percent in the first three months of fis...
Restructuring hitting Bayer Healthcare
Bayer Healthcare is headed for a fresh round of restructuring amid growing worries over the lackluster earnings outlook.
The company is set to deploy the early retirement plans for some 100 employees after it pushe...
Mundipharma Korea launches long-acting painkiller patch
Mundipharma Korea is launching Norspan (buprenorphine) transdermal patch that combines sustained release active ingredient with better analgesic effects and simplicity in use for helping heal chronic pain.
Norspan ...
Ilyang to present positive preclinical results of new influenza antiviral drug
Ilyang Pharmaceutical Co. said Tuesday that it will announce positive data from preclinical study of its new influenza antiviral drug at the 31st Annual Meeting to be hosted by the American Society for Virology and he...
Pharmaceutical firms’ debt ratio stands at 60.8%
The debt ratio of 55 major pharmaceutical firms listed on Seoul bourse posted 60.8 percent last year as they tried to hold more cash
According to Yakup.com, a pharmaceutical information provider, the debt ratio of ...
Daily treatments of Cialis and Zydena draw favorable market response
The daily therapies of Lilly’s Cialis and Dong-A Zydena have enjoyed robust sales ahead of imminent launching of 14 Viagra generics as the main patent for Viagra, the world’s bestselling anti-impotence pill, expires o...
Celltrion to build 112 billion won GMP plant in Ochang
Celltrion, the nation’s foremost biosimilar producer, said yesterday in a regulatory filing that it plans to build a 112 billion won GMP (Good Manufacturing Practice) plant in Ochang, North Chungcheong Province, to ma...
19 drugmakers suffer decline in 3-month OP rate
The major pharmaceutical firms saw their operating profit (OP) rate fall during the first quarter of the year, even before a government-mandated price cut came into effect, according to recent data from Yakup.com, a p...
Convenient stores struggle with drug supply
Domestic convenient stores are poised to market 20 over-the-counter (OTC) drugs such as cold medicine as the National Assembly passed a bill allowing the sale of drugs at retail outlets other than pharmacies on May 2....
